drugset / Trial / NCT01492621
Effect of Antidepressants on White Matter Structure
Phase 4
Unknown
40 enrolled
Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal
Pfizer · collab
NaSingle-groupOpen-labelBasic science
Summary
Subjects with major depression will be evaluated and intensively characterized through questionnaires, computerized cognitive evaluation and laboratory investigations. Magnetic resonance imaging will be used to document baseline white matter structure. subjects will then receive desvenlafaxine which will be adjusted as clinically indicated. After 16 weeks the evaluations will be repeated.
Timeline
- Start
- 2011-11
- Primary completion
- 2013-09
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desvenlafaxine | Other / unclassified | 50 mg | — |
| Subject | Desvenlafaxine | Other / unclassified | 100 mg | — |